BERKELEY, Calif.--(BUSINESS WIRE)--Nov 1, 2023--IMVARIA Inc., a health tech company pioneering AI-driven digital biomarker solutions, today announced a collaboration through a know-how agreement with Mayo Clinic to develop AI designed to significantly improve the analysis and understanding of ...
PETERSBURG, Va.--(BUSINESS WIRE)--Nov 1, 2023--Civica Inc. (Civica, Civica Rx) is proud to announce that pharmaceutical industry leader Bouwien Smits has joined Civica as the new Site Vice President and General Manager of the company’s new sterile injectable manufacturing facility.Smits has ...
JERSEY CITY, N.J. & SAN FRANCISCO--(BUSINESS WIRE)--Nov 1, 2023--Organon (NYSE:OGN) and Sempre Health today announced a strategic partnership designed to motivate eligible patients to refill their prescriptions on time and improve adherence through an innovative pricing program that ...
TORONTO--(BUSINESS WIRE)--Nov 1, 2023--Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage biotechnology company leveraging its hydrogen sulfide platform to develop next-generation therapies targeting pain and inflammation, is pleased to announce the completion of the ...